Literature DB >> 27272798

Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma.

Stefan Aufderklamm1, Jörg Hennenlotter1, Tilman Todenhöfer1, Nicolas Senghaas1, Marcus Scharpf2, Georgios Gakis1, Steffen Rausch1, Johannes Mischinger1, Simone Bier1, Arnulf Stenzl1, Christian Schwentner3, Jens Bedke4.   

Abstract

AIM: The aim of the study was to investigate the clinical impact of the surgical margin width after nephron-sparing surgery (NSS) on the oncological course of renal cell carcinoma (RCC). PATIENTS AND METHODS: The study comprised of 126 RCC patients with NSS between 2002 and 2009. Inclusion criteria were negative resection margins and a tumor diameter of ≤100 mm with the possibility of a complete circumferential histopathological reevaluation. The minimal benign margin width was correlated to the patients' clinical course.
RESULTS: Median safety margin width was revealed to be 1 mm. Nine of 126 patients (7.1%) developed recurrent disease (five local, four distant). All patients with local recurrence had safety margins ≤1 mm, whereas out of 49 patients with a margin >1 mm no one developed local recurrence (p=0.0245). Safety margin ≤1 mm showed associations with increased risk for overall recurrence in univariate and multivariate analysis (p=0.0531 and 0.0539, respectively).
CONCLUSION: Tumor adjacent renal parenchyma may have oncological relevance, corroborating the need for further molecular investigation of tumor-adjacent tissue in RCC. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Renal cell carcinoma; nephron-sparing surgery; oncological outcome; parenchyma; recurrence; safety margin

Mesh:

Year:  2016        PMID: 27272798

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.

Authors:  Dean D Laganosky; Christopher P Filson; Viraj A Master
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.